Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,023,926 papers from all fields of science
Search
Sign In
Create Free Account
DQ 2511
Known as:
DQ-2511
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
ecabapide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Possible mechanisms underlying the suppression of gastric vagal afferents due to ecabapide (DQ-2511), a gastroprokinetic agent, in rats.
S. Hatanaka
,
A. Niijima
,
K. Furuhama
Japanese Journal of Pharmacology
1997
Corpus ID: 37772279
We examined the implication of a nitric oxide (NO)-guanosine 3',5'-cyclic monophosphate (cGMP) cascade in the suppression of…
Expand
1996
1996
Comparative evaluation of DQ‐2511, a novel gastroprokinetic agent, with cisapride in ameliorative action on experimentally induced delayed gastric emptying
S. Hatanaka
,
K. Kawarabayashi
,
M. Iseri
,
K. Tsubokura
,
K. Furuhama
,
A. Nijima
Neurogastroenterology and Motility
1996
Corpus ID: 42148355
We compared the main pharmacological effect of DQ‐2511 (3‐[[[2‐(3,4‐dimethoxyphenyl)‐ethyl]carbamoyl]methyl]amino ‐N…
Expand
1996
1996
Effects of DQ-2511 on neutral activity in afferent and efferent loops of gastric vago-vagal reflex pathways in the rat.
A. Niijima
,
S. Hatanaka
,
K. Furuhama
Journal of autonomic pharmacology
1996
Corpus ID: 22707703
1. DQ-2511 is a new substituted benzamide compound that has gastric prokinetic properties. Actions of the drug on neural…
Expand
1996
1996
A possible mechanism of heinz body hemolytic anemia induced by DQ-2511, a new gastroprokinetic drug, in dogs.
H. Ohno
,
M. Nomura
,
K. Watanabe
Fundamental and Applied Toxicology
1996
Corpus ID: 43899462
A previous study revealed that DQ-2511, a new gastroprokinetic drug, induced hemolytic anemia together with increased Heinz body…
Expand
1995
1995
Pharmacological characteristics of DQ-2511 as a prokinetic agent.
S. Hatanaka
,
T. Hosokami
,
K. Kawarabayashi
,
M. Iseri
,
K. Tsubokura
,
K. Furuhama
Archives internationales de pharmacodynamie et de…
1995
Corpus ID: 7784659
The pharmacological characteristics of DQ-2511, a substituted benzamide (3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl…
Expand
1995
1995
DQ-2511, having an antiulcer action, elicits vasodilation through an increase in cyclic GMP contents in rat arteries.
S. Hatanaka
,
Y. Ryokawa
,
K. Kawarabayashi
,
K. Furuhama
Pharmacology
1995
Corpus ID: 46785371
It has been reported that 3-(([2-(3,4-dimethoxyphenyl)ethyl]carbamoyl)methyl)amino-N-methylbenz amide (DQ-2511: ecabapide…
Expand
1995
1995
Enhancing effect of DQ-2511 on gastric emptying of spontaneously hypertensive rats.
S. Hatanaka
,
K. Kawarabayashi
,
M. Iseri
,
K. Tsubokura
,
K. Furuhama
Life Science
1995
Corpus ID: 5849154
1993
1993
Heinz body hemolytic anemia induced by DQ-2511, a new anti-ulcer drug, in dogs.
H. Ohno
,
H. Tojo
,
K. Kakihata
,
M. Nomura
,
S. Takayama
Fundamental and Applied Toxicology
1993
Corpus ID: 40894417
DQ-2511, a new anti-ulcer drug, was administered to beagle dogs for 4 weeks to investigate the mechanism whereby this drug…
Expand
1992
1992
Syntheses of 2-(3,4-dimethoxyphenyl)ethylamine derivatives and their antiulcer activities.
T. Hosokami
,
M. Kuretani
,
+5 authors
T. Miki
Chemical and pharmaceutical bulletin
1992
Corpus ID: 11131738
A series of acyl derivatives of 2-(3,4-dimethoxyphenyl)ethylamine (4) were synthesized and evaluated for their effectiveness to…
Expand
1990
1990
Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
M. Asano
,
Y. Kurebayashi
,
Y. Ryokawa
,
T. Hashizume
,
A. Akashi
Arzneimittel-Forschung
1990
Corpus ID: 23305745
Effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl] methyl]-amino-N-methylbenzamide (DQ-2511), a newly synthesized compound…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE